Usage of mitochondrial D-loop variation to predict risk for Huntington disease

References

• Acevedo-Torres K, Berríos L, Rosario N, Dufault V, Skatchkov S, Eaton MJ, Torres-Ramos CA, Ayala-Torres S. (2009). Mitochondrial DNA damage is a hallmark of chemically induced and the R6/2 transgenic model of Huntington's disease. DNA Repair 8:126–36
   PubMed Web of Science ®Google Scholar
• Akouchekian M, Houshmand M. (2008). Mitochondrial haplogroup analysis in colorectal cancer: Identification of a high-risk population. Arch Med Sci 4:397–400
   Web of Science ®Google Scholar
• Aral C, Akkiprik M, Caglayan S, Atabey Z, Ozişik G, Bekiroglu N, Ozer A. (2011). Investigation of relationship of the mitochondrial DNA 16189 T>C polymorphism with metabolic syndrome and its associated clinical parameters in Turkish patients. Hormones (Athens) 10:298--303
   Google Scholar
• Banoei MM, Houshmand M, Panahi MS, Shariati P, Rostami M, Manshadi MD, Majidizadeh T. (2007). Huntington's disease and mitochondrial DNA deletions: Event or regular mechanism for mutant huntingtin protein and CAG repeats expansion?! Cell Mol Neurobiol 27:867–75
   Google Scholar
• Boles RG, Zaki EA, Lavenbarg T, Hejazi R, Foran P, Freeborn J, Trilokekar S, McCallum R. (2009). Are pediatric and adult-onset cyclic vomiting syndrome (CVS) biologically different conditions? Relationship of adult-onset CVS with the migraine and pediatric CVS-associated common mtDNA polymorphisms 16519T and 3010A. Neurogastroenterol Motil 21:936–972
   PubMed Web of Science ®Google Scholar
• Chen JB, Lin TK, Liao SC, Lee WC, Lee LC, Liou CW, Wang PW, Tiao MM. (2009). Lack of association between mutations of gene-encoding mitochondrial D310 (displacement loop) mononucleotide repeat and oxidative stress in chronic dialysis patients in Taiwan. J Negat Results Biomed 8:10. doi: 10.1186/1477-5751-8-10
   PubMedGoogle Scholar
• Clayton DA. (2000). Transcription and replication of mitochondrial DNA. Hum Reprod 15 Suppl 2:11–17
   Google Scholar
• Ferreira IL, Nascimento MV, Ribeiro M, Almeida S, Cardoso SM, Grazina M, Pratas J, et al. (2010). Mitochondrial-dependent apoptosis in Huntington's disease human cybrids. Exp Neurol 222:243--55
   PubMed Web of Science ®Google Scholar
• Gusella JF, MacDonald ME. (2000). Molecular genetics: Unmasking polyglutamine triggers in neurodegenerative disease. Nature Rev Neurosci 1:109–15
   PubMedGoogle Scholar
• He Y, Wu J, Dressman DC, Iacobuzio-Donahue C, Markowitz SD, Velculescu VE, Diaz LA Jr, et al. (2010). Heteroplasmic mitochondrial DNA mutations in normal and tumour cells. Nature 464:610–14
   PubMed Web of Science ®Google Scholar
• Hormozian F, Houshmand M, Sanati MH, Ghiasvand M, Banoei MM. (2004). Molecular analysis of (CAG)n repeat causing Huntington’s disease in 34 Iranian families. Ind J Hum Genet 10:53–7
   Google Scholar
• Houshmand M, Panahi MS, Nafisi S, Soltanzadeh A, Alkandari FM. (2006). Identification and sizing of GAA trinucleotide repeat expansion, investigation for D-loop variations and mitochondrial deletions in Iranian patients with Friedreich's ataxia. Mitochondrion 6:82–8
   Google Scholar
• Karbowski M, Neutzner A. (2012). Neurodegeneration as a consequence of failed mitochondrial maintenance. Acta Neuropathol 123:157–71
   PubMed Web of Science ®Google Scholar
• Kasraie S, Houshmand M, Banoei MM, Ahari SE, Panahi MS, Shariati P, Bahar M, Moin M. (2008). Investigation of tRNA(Leu/Lys) and ATPase 6 Genes mutations in Huntington's disease. Cell Mol Neurobiol 28:933–8
   Google Scholar
• Khogali SS, Mayosi BM, Beattie JM, McKenna WJ, Watkins H, Poulton J. (2001). A common mitochondrial DNA variant associated with susceptibility to dilated cardiomyopathy in two different populations. Lancet 357:1265–7
   PubMed Web of Science ®Google Scholar
• Kowall NW, Ferrante RJ. (1998). Huntington’s disease. In: Markesbery M., editors. Neuropathology of dementing disorders. London, UK: Edward Arnold. p 219–56
   Google Scholar
• Levin BC, Cheng H, Reeder DJ. (1999). A human mitochondrial DNA standard reference material for quality control in forensic identification, medical diagnosis, and mutation detection. Genomics 55:135–46
   PubMedGoogle Scholar
• Lin MT, Beal MF. (2006). Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443:787–95
   PubMed Web of Science ®Google Scholar
• Liu VW, Wang Y, Yang HJ, Tsang PC, Ng TY, Wong LC, Nagley P, Ngan HY. (2003). Mitochondrial DNA variant 16189T>C is associated with susceptibility to endometrial cancer. Hum Mutat 22:173–4
   Google Scholar
• Mancuso M, Coppede F, Migliore L, Siciliano G, Murri L. (2006). Mitochondrial dysfunction, oxidative stress and neurodegeneration. J Alzheimers Dis 10:59–73
   PubMed Web of Science ®Google Scholar
• Mao P, Reddy PH. (2011). Aging and amyloid beta-induced oxidative DNA damage and mitochondrial dysfunction in Alzheimer’s disease: Implications for early intervention and therapeutics. Biochim Biophys Acta 1812:1359–70
   PubMed Web of Science ®Google Scholar
• Matrin JB. (1999). Molecular basis of neurodegenerative disorders. New Eng J Med 340:1970–80
   Google Scholar
• Orr HT, Zoghbi HY. (2007). Trinucleotide repeat disorders. Annu Rev Neurosci 30:575–621
   PubMed Web of Science ®Google Scholar
• Palmieri VO, De Rasmo D, Signorile A, Sardanelli AM, Grattagliano I, Minerva F, Cardinale G, et al. (2011). T16189C mitochondrial DNA variant is associated with metabolic syndrome in Caucasian subjects. Nutrition 27:773–7
   PubMed Web of Science ®Google Scholar
• Poulton J, Luan J, Macaulay V, Hennings S, Mitchell J, Wareham NJ. (2002). Type 2 diabetes is associated with a common mitochondrial variant: Evidence from a population-based case-control study. Hum Mol Genet 11:1581–3
   PubMed Web of Science ®Google Scholar
• Reddy PH, Mao P, Manczak M. (2009). Mitochondrial structural and functional dynamics in Huntington's disease. Brain Res Rev 61:33–48
   PubMed Web of Science ®Google Scholar
• Rollins B, Martin MV, Sequeira P, Moon EA, Morgan LZ, Watson SJ, Schatzberg A, et al. (2009). Mitochondrial variants in schizophrenia, bipolar disorder, and major depressive disorder. PLoS One 4:e4913
   PubMed Web of Science ®Google Scholar
• Ruiz-Pesini E, Lott MT, Procaccio V, Poole JC, Brandon MC, Mishmar D, Yi C, et al. (2007). An enhanced MITOMAP with a global mtDNA mutational phylogeny. Nucleic Acids Res 35:D823–8
   PubMed Web of Science ®Google Scholar
• Sotgia F, Martinez-Outschoorn UE, Lisanti MP. (2011). Mitochondrial oxidative stress drives tumor progression and metastasis: Should we use antioxidants as a key component of cancer treatment and prevention? BMC Med 9:62
   PubMed Web of Science ®Google Scholar
• Tanaka N, Goto Y, Akanuma J, Kato M, Kinoshita T, Yamashita F, Tanaka M, Asada T. (2010). Mitochondrial DNA variants in a Japanese population of patients with Alzheimer's disease. Mitochondrion 10:32–7
   PubMed Web of Science ®Google Scholar
• Wallace DC. (1999). Mitochondrial diseases in man and mouse. Science 283:1482–8
   PubMed Web of Science ®Google Scholar
• Weng SW, Liou CW, Lin TK, Wei YH, Lee CF, Eng HL, Chen SD, et al. (2005). Association of mitochondrial deoxyribonucleic acid 16189 variant (T->C transition) with metabolic syndrome in Chinese adults. J Clin Endocrinol Metab 90:5037–40
   PubMed Web of Science ®Google Scholar
• Yang JL, Weissman L, Bohr V, Mattson M. (2008). Mitochondrial DNA damage and repair in neurodegenerative disorders. DNA Repair 7:1110–20
   PubMed Web of Science ®Google Scholar
• Zaki EA, Freilinger T, Klopstock T, Baldwin EE, Heisner KR, Adams K, et al. (2009). Two common mitochondrial DNA polymorphisms are highly associated with migraine headache and cyclic vomiting syndrome. Cephalalgia 29:719–28
   PubMedGoogle Scholar